[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@SiemprePulpo The Octopus Investing
The Octopus Investing posts on X about $nvo, $lly, ceo, aos the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXXXX engagements in the last XX hours.
Engagements: XXXXXXX #
- X Week XXXXXXX +1,933%
- X Month XXXXXXX +1,159%
- X Months XXXXXXX +90%
- X Year XXXXXXX +352%
Mentions: X #
- X Week XX -XX%
- X Month XX +47%
- X Months XXX +71%
- X Year XXX +116%
Followers: XXXXX #
- X Week XXXXX +0.29%
- X Month XXXXX +2.90%
- X Months XXXXX +28%
- X Year XXXXX +145%
CreatorRank: XXXXXXX #
Social Influence
Social category influence finance #1300 stocks #1060
Social topic influence $nvo #1, $lly #1, ceo 4.76%, aos 4.76%, $lonn 4.76%, nvo 4.76%, $dnpwa XXXX%
Top accounts mentioned or mentioned by @vanguardeconomy @joinyellowbrick @idresearch @lateinvest @luki321218611h @mdbbolsa @fredrikkjell @jessmouri @estructurero_87 @fte86
Top assets mentioned Novo-Nordisk (NVO) Eli Lilly and Company (LLY)
Top Social Posts
Top posts by engagements in the last XX hours
"Back in March 2023 Lars Frueergard (former $NVO CEO) mentioned in the podcast In Good Company as president of the European Federation of Pharmaceutical Industries Association (EFPIA) at the time they were pushing to promote these improvements in EU"
X Link 2025-12-11T14:22Z 2059 followers, 2216 engagements
"Lately in X there are only two types of profiles following $NVO as its popularity has declined together with its share price: 🔹Passionate scientific accounts uncovering every single scientific detail about all molecules of the GLP-1 R&D portfolio undergoing clinical trials. 🔹 Accounts following every single commercial deal by $NVO $LLY and others updating valuation models on pricing updates distribution news etc. I enjoy the work done by many on both sides. However little attention is being paid to other key factors such as production technologies distribution network development and"
X Link 2025-12-05T13:43Z 2058 followers, 1526 engagements
"Two days in a row with some positive news for $NVO + one bump in $LLY road (full disclosure of TRIUMPH-4 data still pending though)"
X Link 2025-12-11T15:47Z 2059 followers, 199.6K engagements
"Lonza Group AG $LONN is up +6.5% this morning on its H1 2025 results: 🔹Revenue: +19.0% at CER 🔹CDMO revenue: +23.1% at CER 🔹 Utilization improvement despite weaker CGT & microbial demand 🔹New facilities ramp-up within schedule 🔹Guidance raised: +1% both in sales & EBITDA Looking at positive results in pharma glass packaging manufacturers CROs & CDMOs results biotech demand looks to be finally back 😎"
X Link 2025-07-23T08:27Z 2058 followers, 4185 engagements
"Yesterday $NVO share price dropped more than X% on the news about a new oral GLP-1 candidate which phase II clinical trials showed promising data. This candidate might arrive on the market in X years and requires up to 120mg of API that Structure Therapeutics (a pre-revenue biotech company) or its potential buyer will need to scale 🙄"
X Link 2025-12-09T12:14Z 2058 followers, 1545 engagements
"@luki321218611h @MDBBolsa Mercadona o $DNP.WA"
X Link 2025-12-11T18:08Z 2058 followers, X engagements